CORCEPT THERAPEUTICS INC
CORT
84 insider filings · Latest: Oct 15, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Apr 7, 2026 | Apr 7 4:08 PM | Guyer William | Proposed Sale | 20,000 | $40.85 | $817.0K | — | View → |
| Mar 25, 2026 | Mar 27 8:27 PM | BELANOFF JOSEPH KDirector, Chief Executive Officer | Sale | 26,198 | $50.07 | $1.3M | 2,918,326(I) | View → |
| Mar 25, 2026 | Mar 25 7:49 PM | BELANOFF JOSEPH K | Proposed Sale | 40,000 | $33.82 | $1.4M | — | View → |
| Mar 20, 2026 | Mar 24 8:54 PM | William GuyerChief Development Officer | Sale | 11,767 | $36.01 | $423.7K | 2,231(D) | View → |
| Mar 17, 2026 | Mar 19 9:07 PM | BAKER G LEONARD JRDirector | Purchase | 100,000 | $33.14 | $3.3M | 1,146,631(D) | View → |
| Mar 4, 2026 | Mar 6 9:30 PM | William GuyerChief Development Officer | Sale | 8,233 | $35.99 | $296.3K | 2,231(D) | View → |
| Mar 4, 2026 | Mar 4 9:02 PM | Guyer William | Proposed Sale | 20,000 | $35.28 | $705.6K | — | View → |
| Feb 3, 2026 | Feb 5 10:42 PM | William GuyerChief Development Officer | Sale | 20,000 | $40.87 | $817.3K | 1,235(D) | View → |
| Feb 3, 2026 | Feb 3 4:26 PM | Guyer William | Proposed Sale | 20,000 | $40.71 | $814.2K | — | View → |
| Jan 6, 2026 | Jan 6 5:04 PM | Guyer William | Proposed Sale | 20,000 | $34.95 | $699.0K | — | View → |
| Dec 2, 2025 | Dec 2 3:34 PM | Guyer William | Proposed Sale | 20,000 | $79.78 | $1.6M | — | View → |
| Dec 1, 2025 | Dec 1 7:36 PM | BELANOFF JOSEPH K | Proposed Sale | 40,000 | $79.40 | $3.2M | — | View → |
| Dec 1, 2025 | Dec 1 7:00 PM | Maduck Sean | Proposed Sale | 20,000 | $79.40 | $1.6M | — | View → |
| Dec 1, 2025 | Dec 1 6:50 PM | Lyon Joseph Douglas | Proposed Sale | 5,000 | $79.40 | $397.0K | — | View → |
| Nov 25, 2025 | Nov 25 9:46 PM | Guyer William | Proposed Sale | 4,500 | $80.90 | $364.1K | — | View → |
| Nov 5, 2025 | Nov 5 3:12 PM | Guyer William | Proposed Sale | 20,000 | $71.10 | $1.4M | — | View → |
| Nov 3, 2025 | Nov 3 9:06 PM | BELANOFF JOSEPH K | Proposed Sale | 40,000 | $73.47 | $2.9M | — | View → |
| Nov 3, 2025 | Nov 3 8:31 PM | Lyon Joseph Douglas | Proposed Sale | 5,000 | $73.47 | $367.4K | — | View → |
| Nov 3, 2025 | Nov 3 8:25 PM | Maduck Sean | Proposed Sale | 20,000 | $73.47 | $1.5M | — | View → |
| Oct 10, 2025 | Oct 10 2:44 PM | Swisher Daniel N JR | Proposed Sale | 2,200 | $87.54 | $192.6K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Oct 2, 2026 | Oct 5 11:58 PM | Roberto Wandenkolk VieiraPresident, Oncology | Option Exercise | 8,333 | $21.63 | 133,334(D) | View → |
| Oct 2, 2026 | Oct 5 11:54 PM | Joseph Douglas LyonChief Accounting & Technology Officer | Option Exercise | 9,190 | $19.26 | 44,167(D) | View → |
| Oct 1, 2026 | Oct 5 11:54 PM | Joseph Douglas LyonChief Accounting & Technology Officer | Option Exercise | 810 | $13.56 | 3,357(D) | View → |
| Oct 2, 2026 | Oct 5 11:49 PM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Option Exercise | 24,587 | $8.27 | 41,986(D) | View → |
| Oct 1, 2026 | Oct 5 11:49 PM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Option Exercise | 413 | $8.27 | 66,573(D) | View → |
| Oct 1, 2026 | Oct 5 11:44 PM | Justin Frederick GunnPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Grant/Award | 100,000 | $114.03 | 100,000(D) | View → |
| Sep 17, 2026 | Sep 18 11:47 PM | Gary Charles RobbChief Business Officer | Option Exercise | 17,493 | $8.27 | 182,507(D) | View → |
| Sep 14, 2026 | Sep 16 8:30 PM | Joseph Douglas LyonChief Accounting & Technology Officer | Option Exercise | 10,000 | $13.56 | 4,167(D) | View → |
| Sep 1, 2026 | Sep 4 1:16 AM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Option Exercise | 25,000 | $8.27 | 66,986(D) | View → |
| Sep 2, 2026 | Sep 4 1:02 AM | Roberto Wandenkolk VieiraPresident, Oncology | Option Exercise | 58,333 | $21.63 | 141,667(D) | View → |
| Aug 26, 2026 | Aug 28 8:30 PM | Kimberly ParkDirector | Option Exercise | 30,000 | $13.49 | 30,000(D) | View → |
| Aug 25, 2026 | Aug 27 8:30 PM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Option Exercise | 30,955 | $11.35 | 169,045(D) | View → |
| Aug 14, 2026 | Aug 18 8:30 PM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Option Exercise | 3,664 | $8.27 | 91,986(D) | View → |
| Aug 10, 2026 | Aug 12 8:27 PM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Option Exercise | 1,031 | $8.27 | 95,650(D) | View → |
| Aug 10, 2026 | Aug 12 8:26 PM | William GuyerChief Development Officer | Option Exercise | 16,300 | $21.65 | 110,000(D) | View → |
| Aug 4, 2026 | Aug 6 10:44 PM | William GuyerChief Development Officer | Option Exercise | 3,700 | $21.65 | 126,300(D) | View → |
| Aug 3, 2026 | Aug 5 9:51 PM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Option Exercise | 20,305 | $8.27 | 96,681(D) | View → |
| Jul 30, 2026 | Aug 3 8:30 PM | Atabak MokariChief Financial Officer | Option Exercise | 80,000 | $23.06 | 95,833(D) | View → |
| Jul 15, 2026 | Jul 17 10:31 PM | Atabak MokariChief Financial Officer | Option Exercise | 40,000 | $23.06 | 175,833(D) | View → |
| Jul 7, 2026 | Jul 8 11:54 PM | William GuyerChief Development Officer | Option Exercise | 20,000 | $21.65 | 130,000(D) | View → |
Page 1 of 3
Next →